For centuries people have been puzzled by the inevitability of human aging. For most of the second half of the twentieth century, aging remained a mystery, or an unsolved biological problem. At the end of the 20th century, a remarkable scientific discovery emerged.
Biodesign Institute researcher Stephen Albert Johnston, Ph.D., has received a five-year, $7.5 million grant to develop a preventive vaccine against breast cancer, the second leading cause of death in women.
Cancer Research UK funded scientists have for the first time identified a common genetic variant that can increase a person’s risk of developing bowel cancer. Their findings appear in two papers published online in Nature Genetics.
It infiltrates hospitals as microscopic spores. Its defenses are so strong it can resist most antibiotics. And it kills three times as many people every year as MRSA. But scientists at the University of Nottingham are amassing an arsenal of weapons in preparation for counter offensive against the most deadly of hospital superbugs.
A factor in immune cells regulates human semen and seems to determine whether a man will be fertile, according to a new study.
Scientists have discovered a new type of mouse embryonic stem cell that is the closest counterpart yet to human embryonic stem cells, the National Institutes of Health announced today. The cells are expected to serve as an improved model for human ES cells in studies of regeneration, disease pathology and basic stem cell biology.
The death rate from traffic injuries is higher in Africa than in any other region of the world, and yet research into improving road safety in Africa is scarce, argues Emmanuel Lagarde (French National Institute for Health and Medical Research) in an Essay in PLoS Medicine.
Pioneering work to reduce the use of animals in scientific research — and ultimately remove them from laboratories altogether — has received a major boost at The University of Nottingham.
Neurologix, Inc. (OTC Bulletin Board: NRGX) today announced the publication in the June 23 issue of the journal The Lancet of positive results from the first ever gene therapy trial for Parkinson?s disease and the first report of direct gene transfer into a patient?s own brain cells for any adult neurodegenerative disease.
In a survey of more than one thousand infertility patients with frozen embryos, 60 percent of patients report that they are likely to donate their embryos to stem cell research, a level of donation that could result in roughly 2000 to 3000 new embryonic stem cell lines.